Sunshine Biopharma (SBFM) Retained Earnings: 2010-2025
Historic Retained Earnings for Sunshine Biopharma (SBFM) over the last 13 years, with Sep 2025 value amounting to -$72.9 million.
- Sunshine Biopharma's Retained Earnings fell 8.96% to -$72.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.9 million, marking a year-over-year decrease of 8.96%. This contributed to the annual value of -$69.0 million for FY2024, which is 8.03% down from last year.
- Per Sunshine Biopharma's latest filing, its Retained Earnings stood at -$72.9 million for Q3 2025, which was down 1.23% from -$72.0 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Retained Earnings registered a high of -$26.4 million during Q1 2021, and its lowest value of -$72.9 million during Q3 2025.
- In the last 3 years, Sunshine Biopharma's Retained Earnings had a median value of -$65.7 million in 2024 and averaged -$66.5 million.
- Data for Sunshine Biopharma's Retained Earnings shows a maximum YoY tumbled of 81.90% (in 2022) over the last 5 years.
- Quarterly analysis of 5 years shows Sunshine Biopharma's Retained Earnings stood at -$32.7 million in 2021, then crashed by 81.90% to -$59.4 million in 2022, then decreased by 7.59% to -$63.9 million in 2023, then declined by 8.03% to -$69.0 million in 2024, then fell by 8.96% to -$72.9 million in 2025.
- Its Retained Earnings stands at -$72.9 million for Q3 2025, versus -$72.0 million for Q2 2025 and -$70.2 million for Q1 2025.